Application 211442
- Type
- ANDA
- Sponsor
- APOTEX INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DAPAGLIFLOZIN | DAPAGLIFLOZIN | TABLET;ORAL | 40MG | No | No |
| 002 | DAPAGLIFLOZIN | DAPAGLIFLOZIN | TABLET;ORAL | 80MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | Alembic Pharmaceuticals Limited | d44f7eed-dd51-40d1-8408-8fb331e1f1f6 | 2026-04-21 | Warnings, Adverse reactions | DAPAGLIFLOZIN DAPAGLIFLOZIN |
| Dapagliflozin | DAPAGLIFLOZIN | Apotex Corp. | bd9766c5-104f-4636-897d-b6c92eb94f18 | 2026-04-10 | Warnings, Adverse reactions | Dapagliflozin DAPAGLIFLOZIN |
| Dapagliflozin | DAPAGLIFLOZIN | Zydus Lifesciences Limited | db668c5c-2d49-41c8-8ffd-c2b2652b621a | 2026-04-06 | Dapagliflozin DAPAGLIFLOZIN | |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | Bryant Ranch Prepack | 979205ee-b0b8-4483-ae61-f283f750bb7f | 2024-08-08 | Warnings, Adverse reactions | DAPAGLIFLOZIN DAPAGLIFLOZIN |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | A-S Medication Solutions | 82cdd5ad-df2b-4bdd-a3a6-a059040100b4 | 2024-06-28 | Warnings, Adverse reactions | DAPAGLIFLOZIN DAPAGLIFLOZIN |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | A-S Medication Solutions | 87521963-0d2a-4a2a-89c6-d50e8582419e | 2024-06-28 | Warnings, Adverse reactions | DAPAGLIFLOZIN DAPAGLIFLOZIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.